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ABSTRACT 
Salix aegyptiaca has been used traditionally from the ancient time for its beneficial effects. The protective action of this plant is not 
well understood so far. Oxidative stress and inflammation are generally linked with carcinogenesis. In the present study, antioxidant, 
anti-inflammatory and anticancer activities of hydroethanolic bark extract of Salix aegyptiaca have been studied. The results of 
DPPH assay indicated the free radical scavenging ability of the bark extract (2-20 µg/ml). The inhibition of ˙OH radical induced 
damage of pBR322 plasmid DNA by the extract (20 µg/ml) depicted its antioxidant property. This bark extract (5-800 µg/ml) 
exhibited the anti-inflammatory activity against heat induced protein denaturation. The medicinal property of S. aegyptiaca could be 
attributed to its free radicals scavenging ability and anti-inflammatory activity. Further, the extract (5-40 µg/ml) has shown 
anticancer activity against human hepatocellular carcinoma (HepG2) cells. However, the underlying mechanisms related to its 
anticancer effect need to be explored. 
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Oxidative stress refers to the increased level of free 
radicals mainly reactive oxygen species (ROS) along 
with reactive nitrogen species (RNS) which cause 
damage to main cellular constituents like DNA, lipid 
and protein. Oxidative damage could lead to the 
initiation and development of several health 
complications such as diabetes, Alzheimer’s disease, 
artherosclerosis, cardiovascular problems and various 
types of cancers
1,2
. ROS apart from damaging the 
cellular macromolecules, also lead to the secretion of 
chemotactic factors, stimulation of inflammatory 
process and several growth factors, and activation of 
many transcription factors and oncogenes
3
. 
Mitochondria, peroxisomes, cytochrome P450 
metabolism and inflammatory responses are the 
endogenous sources of ROS generation
4
. The 
endogenous ROS production is scavenged by 
endogenous and exogenous antioxidants to avoid their 
detrimental effects. 
Liver cancer is one of most common cancers worldwide. 
The developing countries in South-East Asia and Africa 
account for majority of these cases (more than 83% of 
total liver cancer cases) and cases are being increased in 
the industrially developed states
5
. According to 
GLOBOCAN, 2012, liver cancer has been reported as 
fifth most common cancer found in men and ninth in 
women. It ranked second according to the cancer 
mortality rate worldwide
6
. In 2012, there were around 
782,500 new cases and 745,500 deaths found due to 
liver cancer globally
7
. Salix aegyptiaca, commonly 
known as Musk willow, is a diecious flowering plant. It 
Nauman et al                                                                                            Journal of Drug Delivery & Therapeutics. 2018; 8(4):272-276           
ISSN: 2250-1177                                                                             [273]                                                                             CODEN (USA): JDDTAO 
is mainly cultivated in province of Iran
8
. From ancient 
period, it has been traditionally used in Iran as 
cardioprotectant, gastroprotectant, laxative, sedative, 
nervonic, hypnotic, antihelmintic and vermifuge etc.
9
. 
Some recent reports showed anticancer activity of bark 
extract of S. aegyptiaca against human colon cancer cell 
lines and mouse model
10,11,12
.  
In the present study, an attempt was made to study the 
free radical scavenging activity of hydroethanolic 
extract of S. aegyptiaca bark using DPPH assay, and its 
protecting role was also assessed by utilizing a method 
based on the induction of DNA damage in the form of 
single strand break by Fenton reagent generated ˙OH 
radicals. The anti-inflammatory activity of this extract 
was also tested against heat induced protein 
denaturation. Further, the anticancer activity of the 
extract against human hepatocellular carcinoma cells, 
HepG2 was analyzed using cell viability assay. 
2. MATERIALS AND METHODS 
2.1 Cell lines and reagents 
HepG2, a human hepatocellular carcinoma cell line, was 
obtained from National Centre for Cell Science (NCCS), 
Pune, India. Cells were grown in Dulbecco’s modified 
Eagles medium (DMEM; Sigma, Saint Louis, MO, 
USA) supplemented with 10% fetal bovine serum 
(Gibco) and 1% penicillin-streptomycin (Himedia, 
India) at 37°C with 5% CO2. S. aegyptiaca bark extract 
was dissolved in dimethyl sulfoxide (DMSO). The final 
concentration of DMSO in the medium was kept 0.1% 
(v/v) in all treatments including control. 1,1-Diphenyl-2-
picrylhydrazyl (DPPH), 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) and DMSO 
were obtained from Sigma (Saint Louis, MO, USA). 
pBR322 plasmid DNA was obtained from Thermo 
Fisher Scientific (Waltham, MA, USA). The rest of the 
chemicals used were procured from local firms (India) 
and were of highest purity grade. 
2.2 Preparation of hydroethanolic extract of S. 
aegyptiaca stem bark 
The stem bark of S. aegyptiaca was collected from the 
garden in Qazwin, Iran. The plant was identified by the 
botanist on the morphological basis and deposited 
(Sample no. 20150217) in the Department of 
Biotechnology, Jamia Millia Islamia, New Delhi, India. 
The bark was shade dried and powered to make a 
hydroethanolic extract (water: ethanol; 20:80 v/v). The 
powder was dissolved in solvent with ratio of 1:10 
(w/v). The solution was kept on continuous shaking at 
30 °C for 48 h followed by the filtration through 
Whatman (No.1) filter paper. The supernatant was 
concentrated using rotary evaporator (Buchi R-300) at 
45°C followed by the desiccation through lyophilizer. 
2.3 Determination of antioxidant activity by DPPH 
assay 
The free radical scavenging activities of S. aegyptiaca 
bark extract was measured by 1,1-Diphenyl-2-
picrylhydrazyl (DPPH) assay as carried out by G. C. 
Yen with slight modification
13
. Briefly, 1.3 ml of 
methanolic solution of DPPH (100 µM) was added to 
varying concentration of S. aegyptiaca bark extract (2-
20 µg/ml). The reaction was incubated at room 
temperature for 30 min in dark. The absorbance of the 
residual DPPH solution was determined at 517 nm in a 
UV-1800 spectrophotometer (Shimadzu Corp). BHT 
(Butylhydroxytoluene) was used as positive control. The 
percent DPPH radicals scavenging effect was calculated 
using following formula, 
% DPPH scavenging effect =  
                      [(Abscontrol - Abssample)/Abscontrol] x 100 
Where, Abscontrol is the absorbance of DPPH radical + 
methanol and Abssample is absorbance of DPPH radical + 
sample extract/standard 
2.4 Determination of antioxidant activity by DNA 
nicking assay 
DNA nicking assay was carried out as described by Lee 
et al 2002
14. 
Fenton reagent was used to generate the 
hydroxyl free radicals (˙OH) which reacts with pBR322 
plasmid DNA and damages its structure. S. aegyptiaca 
bark extract (20 µg/ml) were added to the reaction 
mixture (20 µl) containing 0.5 µg of pBR322 and 
Fenton reagent (30 mM H2O2, 50 µM ascorbic acid, 80 
µM FeCl3). After incubation of 30 min at 37 °C, 
analysis was done by running the samples on 1% 
agarose gel electrophoresis (Mini Sub-Cell GT, Biorad) 
followed by ethidium bromide staining. Gel 
documentation system (FluorChem HD2) was used to 
visualize the bands. The band intensity was analyzed by 
ImageJ software (NIH, USA). 
2.5 Determination of anti-inflammatory activity by 
protein denaturation assay 
The anti-inflammatory activity of S. aegyptiaca bark 
extract was studied by the method described by H. M. 
Arif Ullah
15
. The final reaction mixture contained 0.2 ml 
of egg albumin, 2.8 ml of phosphate buffer saline (PBS) 
and 2 ml of varying concentrations of the S. aegyptiaca 
bark extract. The final concentration of extract was kept 
50-800 µg/ml.  Sodium diclofenac was used as positive 
control. The tubes containing the mixture were 
incubated at 37 ºC for 15 min followed by heating at 70 
ºC for 5 min. The tubes were allowed to cool and the 
absorbance was measured at 660 nm. The percent 
inhibition of protein denaturation was calculated by 
using the following formula, 
% Inhibition of protein denaturation = [(Abscontrol – 
Abssample) / Abscontrol] x 100 
Where, Abscontrol is the absorbance of control and 
Abssample is absorbance of extract/standard. 
2.6 Determination of cell viability by MTT assay 
Five thousand HepG2 cells were seeded in 96 well 
culture plate and incubated for 24 h. Cells were then 
treated with DMSO or 5-40µg/ml of S. aegyptiaca bark 
extract for 48 h. Then 100 µl of MTT solution (5mg/ml 
in PBS) was added to each well and incubated in 5 % 
CO2 incubator for 4 h. The MTT solution was removed 
without disturbing the cells and 100 µl DMSO was 
added to each well to dissolve formazan crystals. After 
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incubation of 10 min in dark, the wells were read in 
ELISA plate reader at 570 nm wavelength
16
.  
2.7 Statistical analysis 
The values were presented as mean ± SEM. The mean 
and significance of the differences between the data 
pairs was calculated by t-test (SigmaPlot 8.0). A value 
of p < 0.05 was considered significant. 
3. RESULTS 
3.1 S. aegyptiaca bark extract scavenges DPPH free 
radicals 
A varying range of S. aegyptiaca bark extract 
concentration (2-20 µg/ml) exhibited the scavenging of 
DPPH radicals in concentration dependent manner. The 
IC50 value of the extract was found to be 17.71 ± 0.34. 
BHT was used as positive control for comparison. The 
results are shown in Figure 1. 
 
Figure 1: Free radical scavenging property of S. 
aegyptiaca barks extract. Data represents percent 
inhibition of DPPH free radicals through DPPH assay. 
Methanolic solution of DPPH was added to different 
concentrations of S. aegyptiaca bark extract (2-20 
µg/ml). The reaction was incubated at room temperature 
for 30 min in dark. The absorbance of the residual 
DPPH solution was determined at 517 nm. BHT was 
used as positive control. Values are represented as mean 
± SEM of three samples. Abbreviations: BHT; 
Butylhydroxytoluene. 
3.2 S. aegyptiaca bark extract protects DNA against 
˙OH radicals 
S. aegyptiaca bark extract (20 µg/ml) exhibited 
protective role against DNA damage induced by ˙OH 
radicals. For this assay, 20 µg/ml concentration was 
selected on the basis of IC50value (17.71 ± 0.34) of this 
extract which was determined by DPPH assay. The 
damage was determined in terms of conversion of Form 
I of DNA (super coiled) into its Form II (relaxed) and 
Form III (linear). When the supercoiled pBR322 
plasmid DNA incubated in presence of the Fenton 
reagent, the Form I of DNA was changed into for II 
(Lane: 3). The extent of conversion into Form III was 
relatively very small. The bark extract inhibited the 
conversion of Form I into Form II (Lane: 4) against 
Fenton reagent. The results can be seen in Figure 2. 
 
Figure 2: Antioxidant activity of S. aegyptiaca barks 
extract against ˙OH radicals causing DNA nick. Fenton 
reagent was added to 0.5 µg of pBR322 plasmid DNA in 
absence or presence of S. aegyptiaca bark extract. The 
mixture was incubated for 30 min at 37°C. After 
incubation the samples were analyzed by 1% agarose gel 
electrophoresis followed by ethidium bromide staining. 
Abbreviations: FR; Fenton reagent and SA; S. 
aegyptiaca bark extract.  
3.3 S. aegyptiaca bark extract exhibits anti-
inflammatory activity  
The anti-inflammatory activity of the extract (50-800 
µg/ml) was determined by assessing its effect on 
inhibition of heat induced protein denaturation. The 
extract significantly inhibited the protein denaturation in 
concentration-dependent manner by 8.28 % (p < 0.05), 
18.25 % (p < 0.005), 43.09 % (p < 0.005), 50.53 % (p < 
0.005) and 63.48 % (p < 0.005) with the treatment 50, 
100, 200, 400 and 800 µg/ml of S. aegyptiaca bark 
extract. The results are depicted in Figure 3. 
 
Figure 3: Anti-inflammatory activity of S. aegyptiaca 
barks extract. The final reaction mixture contained 0.2 
ml of egg albumin, 2.8 ml of phosphate buffer saline 
(PBS) and 2 ml of varying concentrations of the S. 
aegyptiaca bark extract (50-800 µg/ml). The tubes 
containing reaction mixture were incubated at 37 ºC for 
15 min followed by heating at 70 ºC for 5 min. The 
tubes were allowed to cool and absorbance was 
measured at 660 nm. Sodium diclofenac was used as a 
positive control. Values are represented as percent of 
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control calculated by mean of three samples. 
§
(p < 
0.005) represents significant changes relative to control.  
3.4 S. aegyptiaca bark extract decreases the cancer 
cell viability 
The treatment of S. aegyptiaca bark extract on HepG2 
cells exhibited the decrease in cell viability at 48 h 
determined by MTT assay. The cell viability of HepG2 
cells was significantly decreased by 33. 79 % (p < 0.01) 
and 43.78 % (p < 0.01) with the treatment of 20 and 40 
µg/ml of bark extract, respectively. The results are 
shown in Figure 4. 
 
Figure 4: Inhibitory effect of S. aegyptiaca barks 
extract on viability of HepG2 cells. Cells were treated 
with DMSO or 5-40 µg/ml of S. aegyptiaca bark extract 
for 48 h. Then, 100 µl of MTT solution (5 mg/ml in 
PBS) was added to each well and incubated in 5 % CO2 
incubator for 4 h. The MTT solution was removed and 
100 µl DMSO was added to each well to dissolve 
formazan crystals. After incubation of 10 min in dark, 
the wells were read in ELISA plate reader at 570 nm. 
Values are represented as mean ± SEM of three samples. 
#





O2 (singlet oxygen), O2˙
-
 (superoxide), H2O2 
(hydrogen peroxide), ˙OH (hydroxyl), NO˙ (nitric 
oxide), HO2˙ (per hydroxyl), ROO˙ (peroxyl) and RO˙ 
(alkoxyl) are produced in mammalian body and result in 
the development of oxidative stress
17
. This excessive 
generation of ROS consequently leads to the cellular 
damage, which finally cause the induction of many 
pathological complications. S. aegyptiaca, being a plant 
with medicinal value, is supposed to possess antioxidant 
activity. Expectedly, in the present study, 
hydroethanolic extract of S. aegyptiaca scavenged the 
DPPH free radicals which indicated its antioxidant 
activity.  
The DNA damage is considered to be one of the critical 
events in the cell damage. The ˙OH free radicals almost 
exclusively interact with DNA and cause strand breaks 
by removing the phosphate group from its backbone
18
. 
In the present study, the supercoiled pBR322 plasmid 
DNA was incubated in presence of the Fenton reagent 
along with or without the bark extract. Fenton reagent 
produces the ˙OH free radicals which attack on 
supercoiled DNA (Form I) to convert it into relaxed 
DNA (Form II). The bark extract was found to inhibit 
the conversion of Form I into Form II (indicative of the 
single strand breaks). The protection of supercoiled 
DNA structure (Form I) could have occurred due to 
inactivation of ˙OH free radicals. The main detrimental 
effects are performed by ˙OH free radicals being the 
most reactive free radical
19
 with a shortest biological 
half-life
20
. From the above findings, it could be 
concluded that S. aegyptiaca has property to scavenge 
˙OH and other free radicals. The antioxidant activity of 
this bark extract may be attributed by the presence of 
various phenolic compounds such as gallic acid, caffeic 
acid, vanillin, p-coumaric acid, myricetin, catechin, 
epigallatocatechin gallate, rutin and quercetin, which 
were determined by high performance liquid 
chromatography in bark extract of S. aegyptiaca
21
.  
Now, it is well established that initiation and 
progression of many cancers originate from 
inflammation, hence identified as a hallmark of cancer 
thereby it has been turned out as one of the main focus 
for drug development studies. The inflammatory cells 
markedly contribute to the tumor microenvironment, 
promoting the neoplastic process and aiding in the cell 
proliferation, survival and migration
22
. The secretion of 
chemokines, cytokines, certain growth factors, and 
proteases by inflammatory cells could lead to the 
initiation and promotion of cancer
23
. In our study, S. 
aegyptiaca bark extract showed anti-inflammatory 
activity which might be ascribed to the anticancer 
potential of this extract as it exhibited decrease in cell 
viability of human hepatocellular carcinoma cells, 
HepG2. Hepatocellular carcinoma is the most common 
type of primary liver cancer (PLC) that accounts for 
approximately 75-90 % of total PLC
24
 and a major 
health issue in developing countries.  
The underlying mechanisms related to anticancer 
efficacy of S. aegyptiaca bark extract are yet to be 
explored, however some studies showed that the 
inhibition of colon cancer cells proliferation was 
mediated through G1/S cell cycle arrest and induction of 
apoptosis through p53 dependent pathway. Other 
pathways include the inhibition of PI3K/Akt and MAP 
Kinase pathways, and inhibition of epithelial to 
mesenchymal transition with the treatment of S. 
aegyptiaca bark extract
11,12
. Ethanolic extract of S. 
aegyptiaca bark exhibited chemopreventive efficacy 
against 1,2-dimethylhydrazine induced colon 
carcinogenesis in mice through antioxidant and anti-
inflammatory activities
10
. The above findings strongly 
indicate that S. aegyptiaca bark extract may show 
anticancer efficacy against hepatocellular carcinoma in 
animal models.  
5. CONCLUSION  
Overall, the present study suggests the potential of S. 
aegyptiaca bark extract to scavenge the free radicals, 
inhibit the inflammation and cell viability of 
hepatocellular carcinoma cells, HepG2. The antioxidant 
and anti-inflammatory activity of this extract might be 
responsible for its efficacy against several health 
complications including cancer.  
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